Fusion Didn’t Get Regulatory Clarity. It Got a Starting Gun.

People think nuclear fusion’s regulatory path cleared when Congress decoupled fusion from fission.

They’re wrong.

That wasn’t the finish line.

It was the starting gun.

And the next phase is where most of the risk—and the opportunity—actually sits.

In July 2024, Congress passed the ADVANCE Act, including the Fusion Energy Act of 2024, formally separating nuclear fusion from the regulatory framework governing fission.

On paper, that looked like clarity.

A decades-long overhang—treating fusion like fission—was removed.

For many investors, that was the signal:

the regulatory risk is gone, and the market is open.

But that only solved the first problem.

It did not solve the harder one:

how fusion actually gets governed, funded, and scaled.

That part is still being written.

From where we sit, the bill didn’t unlock capital.

It validated momentum that was already there.

Early-stage fusion companies were already raising pre-seed and seed rounds—driven less by regulatory change and more by technical milestones and the pullback of non-dilutive funding like SBIRs.

Series A and B capital won’t be driven by legislation.

It will be driven by:

• repeatable technical progress

• credible timelines to commercialization

• and capital efficiency in a notoriously expensive sector

At the same time, the regulatory picture remains incomplete.

Proposals like HR 6709 and S 3437 aim to create an Office of Nuclear Fusion within the Department of Energy.

Directionally, that’s positive.

But it introduces a different risk:

the government shaping the market before the technology converges.

Backing specific approaches too early—or defining standards prematurely—can distort competition and slow the very innovation the policy is meant to accelerate.

This is a mistake we see over and over again:

Investors confuse legislative action with regulatory clarity.

They are not the same.

Legislation signals intent.
Regulation defines reality.

And in between, there’s a long, messy phase where:

• agencies interpret mandates

• standards get drafted and redrafted

• funding priorities shift

• and early deployments test what actually works

That’s where markets are made—or broken.

We’ve seen this pattern in:

• rideshare

• telehealth

• mobile voting

Fusion is now entering that exact phase.

Not clarity.

Construction.

This is the window most investors miss.

Because it’s uncomfortable.

The rules aren’t clear.
The timelines aren’t clean.
And the risk doesn’t model neatly.

But this is where the real advantage sits.

Over the next 2–5 years, fusion will move through its true regulatory buildout:

• safety frameworks

• permitting pathways

• grid integration requirements

• federal and state alignment on deployment

And those decisions will determine:

which technologies scale, which stall, and which never make it out of the lab.

There’s another dynamic here that most investors are underweighting:

the first successful deployment doesn’t just prove the technology—it shapes the rules.

If the policy goal is to accelerate the launch of one or more fusion plants, the first company to reach that milestone won’t just gain operational advantage.

It will gain regulatory influence.

That creates a real risk of regulatory capture:

• standards built around one technical approach

• safety frameworks optimized for one design

• compliance requirements that disadvantage alternatives

Some level of standard-setting is necessary to build trust and accelerate deployment.

But if those standards harden too early:

the market doesn’t select the best technology
it selects the first one that made it through the system

For us, this is exactly the point of entry.

Not after the rules are set.

But while they’re being written.

While we have bet on our horse, we don’t see a single fusion approach winning today.

The science hasn’t converged—and policy shouldn’t force it to.

Instead, we focus on what this phase requires:

• technologies that can hit milestones without requiring massive, continuous capital

• systems built for compliance and safety from day one

• infrastructure that supports deployment, not just breakthrough

Because in markets like this:

the winners aren’t just the ones with the best physics
they’re the ones that can navigate the system that determines whether that physics ever reaches the grid

We’ll be watching how this next phase unfolds closely.

Not just which companies hit technical milestones—

but how regulators:

• define safety

• structure approvals

• and signal long-term support

Because those decisions will shape the market more than any single breakthrough.

This is exactly what we mean by Regulation as Alpha.

Most investors wait for clarity.

We invest in the window before it.

When:

• the rules are forming

• the risks are mispriced

• and the market hasn’t caught up yet

Because the market isn’t just growing.

It’s unlocking.

About the Author
I’m Michael O’Brien, Managing Partner at Síol. We invest in the belief that regulation isn’t a risk—it’s a source of alpha. We back founders building in heavily regulated markets before the policy settles, turning complexity into a durable competitive advantage.

Building in the friction? I’d love to hear about your moat.
Exploring policy-driven alpha? Let’s discuss how we’re underwriting the next wave of market inflection points.

📩 mob@siol.vc | LinkedIn